Help | RSS Feed



MiMedx Group, Inc. (OTCMKT:MDXG) Seasonal Chart

MDXG Relative to the S&P 500
MDXG Relative to the S&P 500

MDXG Relative to the Sector
MDXG Relative to the Sector

Monthly Seasonal MiMedx Group, Inc. (OTCMKT:MDXG)

Seasonal Chart Analysis

Analysis of the MiMedx Group, Inc. (OTCMKT:MDXG) seasonal charts above shows that a Buy Date of May 2 and a Sell Date of July 23 has resulted in a geometric average return of 13.52% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 10 of those periods. This is a very good rate of success, but the return underperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 5.92% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from human amniotic membrane and birth tissues and human skin and bone. Its products are primarily targeted toward the wound-care, surgical, sports medicine, and orthopedics markets. MiMedx’s key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. It also sells OrthoFlo, an allograft derived from amniotic fluid. In addition, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

To download MDXG seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore